Literature DB >> 6497415

Essential primary cutis verticis gyrata. Treatment with the scalp reduction procedure.

J M Garden, J K Robinson.   

Abstract

A case of cutis verticis gyrata (CVG) occurred in a patient with no known associated disorders. Under the present classification system, patients with primary CVG are all grouped together. We propose subclassifying patients with primary CVG into two groups: those with associated neurologic and ophthalmologic diseases and those without. Our patient was treated with a scalp reduction procedure.

Entities:  

Mesh:

Year:  1984        PMID: 6497415

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  7 in total

1.  [Asymptomatic cerebriform folds of the scalp. Diagnosis: primary Cutis verticis gyrata (CVG)].

Authors:  L Schöttler; N Denisjuk; A Körber; S Grabbe; J Dissemond
Journal:  Hautarzt       Date:  2007-12       Impact factor: 0.751

2.  [Cutis verticis gyrata with a combined blue and congenital dermal nevus].

Authors:  C Mühlhoff; M Megahed
Journal:  Hautarzt       Date:  2010-11       Impact factor: 0.751

3.  Congenital Primary Essential Cutis Verticis Gyrata.

Authors:  Andreas M Lamelas; Peter J Taub; Lester Silver; Aron Kressel
Journal:  Eplasty       Date:  2016-04-12

4.  Idiopathic Cutis Verticis Gyrata in a Female.

Authors:  Mohamed Amine Ennouhi; Alae Guerrouani; Abdennacer Moussaoui
Journal:  Cureus       Date:  2018-01-23

5.  Primary essential cutis verticis gyrata.

Authors:  Isa Félix Adôrno; Rômulo Florêncio Tristão Santos; Thiago Franchi Nunes; Gabriel Barbosa Sandim; Edson Marchiori
Journal:  Radiol Bras       Date:  2019 Jul-Aug

6.  Scalp expansion for giant cutis verticis gyrata secondary to cerebriform intradermal nevus.

Authors:  Wenfang Dong; Huan Wang; Fei Fan
Journal:  J Int Med Res       Date:  2020-12       Impact factor: 1.671

Review 7.  A rare cutis verticis gyrata secondary to cerebriform intradermal nevus: case report and literature review.

Authors:  Weiliang Zeng; Lili Guo
Journal:  BMC Surg       Date:  2021-05-04       Impact factor: 2.102

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.